FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 89 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,945,000 | +189.6% | 1,100,000 | 0.0% | 0.58% | +256.2% |
| Q2 2022 | $7,579,000 | -25.9% | 1,100,000 | 0.0% | 0.16% | -24.3% |
| Q1 2022 | $10,230,000 | -34.6% | 1,100,000 | 0.0% | 0.21% | -11.6% |
| Q4 2021 | $15,642,000 | -38.7% | 1,100,000 | 0.0% | 0.24% | -27.5% |
| Q3 2021 | $25,509,000 | -6.8% | 1,100,000 | 0.0% | 0.33% | +18.4% |
| Q2 2021 | $27,379,000 | -11.2% | 1,100,000 | 0.0% | 0.28% | -7.5% |
| Q1 2021 | $30,822,000 | -19.7% | 1,100,000 | 0.0% | 0.30% | 0.0% |
| Q4 2020 | $38,390,000 | +54.1% | 1,100,000 | +120.0% | 0.30% | +61.4% |
| Q3 2020 | $24,920,000 | +7.2% | 500,000 | 0.0% | 0.19% | -10.8% |
| Q2 2020 | $23,245,000 | – | 500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |